- Last Close 283.09
- Sector Healthcare
- Industry Medical Devices
- Investment Style Mid Growth
- Day Range 280.49 – 284.05
- Year Range 192.33 – 335.91
- Market Cap 19.7302 Bil
- Volume / Avg 396,601.0 / 913,330.7
- Price / Sales 14.39
- Price / Book 39.00
- Forward Div Yield —
- Trailing Div Yield —
Morningstar‘s Stock Analysis PODD
Insulet Earnings: The Launch of Omnipod 5 Powers Strong Start to 2023
Company Profile PODD
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the U.S. Food and Drug Administration in 2005, approximately 360,000 insulin-dependent diabetics are using it worldwide.
Acton, MA, 01720
Related Articles PODD
Markets Brief: Why October CPI Report Forecasts Have Fed Policy Hanging in the Balance
Morningstar analysts hand-select direct competitors or comparable companies to provide context on the strength and durability of PODD’s competitive advantage.
|+$1.75 (0.62%)||+$0.91 (0.90%)||+$3.21 (2.65%)||+$0.63 (0.76%)|
|19.73 Bil||176.83 Bil||48.20 Bil||111.43 Bil|
|Medical Devices||Medical Devices||Medical Devices||Medical Devices|
* Trading data in this section is delayed by at least 15 minutes.
FAQs for Insulet Corp Stock
No. PODD does not currently have a forward dividend yield.
Dividend yield allows investors, particularly those interested in dividend-paying stocks, to compare the relationship between a stock’s price and how it rewards stockholders through dividends. The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.
Learn more about dividend yield.
PODD’s market cap is 19.73 Bil.
Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares. It’s often used to measure a company’s size. In the Morningstar Style Box, large-cap names account for the largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies.
Learn more about market capitalization.
PODD’s stock style is Mid Growth.
Style is an investment factor that has a meaningful impact on investment risk and returns. Style is calculated by combining value and growth scores, which are first individually calculated.
High-growth stocks tend to represent the technology, healthcare, and communications sectors. They rarely distribute dividends to shareholders, opting for reinvestment in their businesses. More value-oriented stocks tend to represent financial services, utilities, and energy stocks. These are established companies that reliably pay dividends.
Learn more about style.
PODD’s price/sales is 14.39.
Price/sales represents the amount an investor is willing to pay for a dollar generated from a particular company’s sales or revenues.
PODD’s price/forward earnings is 28134.00.
Forward P/E gives some indication of how cheap or expensive a stock is compared with consensus earnings estimates. The lower the Forward P/E, the cheaper the stock.
PODD’s price/book is 39.00.
Price/book ratio can tell investors approximately how much they’re paying for a company’s assets, based on historical, rather than current, valuations. Historical valuations generally do not reflect a company’s current market value. Value investors frequently look for companies that have low price/book ratios.
See PODD’s valuation ratios compared to the Market Index.
PODD’s beta can be found in Trading Information at the top of this page.
A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.
Compare PODD’s historical performance against its industry peers and the overall market.